日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma

CheckMate 140 是一项针对复发/难治性滤泡性淋巴瘤的 2 期研究,旨在评估纳武利尤单抗的疗效和安全性。

Armand, Philippe; Janssens, Ann; Gritti, Giuseppe; Radford, John; Timmerman, John; Pinto, Antonio; Mercadal Vilchez, Santiago; Johnson, Peter; Cunningham, David; Leonard, John P; Rodig, Scott J; Martín-Regueira, Patricia; Sumbul, Anne; Samakoglu, Selda; Tang, Hao; Ansell, Stephen M

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study

纳武利尤单抗治疗不适合或自体移植失败的复发/难治性弥漫性大B细胞淋巴瘤患者:一项单臂II期研究

Ansell, Stephen M; Minnema, Monique C; Johnson, Peter; Timmerman, John M; Armand, Philippe; Shipp, Margaret A; Rodig, Scott J; Ligon, Azra H; Roemer, Margaretha G M; Reddy, Nishitha; Cohen, Jonathon B; Assouline, Sarit; Poon, Michelle; Sharma, Manish; Kato, Kazunobu; Samakoglu, Selda; Sumbul, Anne; Grigg, Andrew

Pleiotropic stromal effects of vascular endothelial growth factor receptor 2 antibody therapy in renal cell carcinoma models.

血管内皮生长因子受体 2 抗体疗法在肾细胞癌模型中的多效性基质效应

Duignan Inga J, Corcoran Erik, Pennello Anthony, Plym Mary Jane, Amatulli Michael, Claros Nidia, Iacolina Michelle, Youssoufian Hagop, Witte Larry, Samakoglu Selda, Schwartz Jonathan, Surguladze David, Tonra James R

Quantitative analysis of clinically relevant mutations occurring in lymphoid cells harboring gamma-retrovirus-encoded hsvtk suicide genes

含有γ-逆转录病毒编码的 hsvtk 自杀基因的淋巴样细胞中发生的临床相关突变的定量分析

X Wang, M Olszewska, V Capacio, J Stefanski, M Przybylowski, S Samakoglu, A H Chang, M Sadelain, I Rivière